More than 38 million Americans suffer from migraine. It is the sixth most disabling neurologic disease globally, according to the World Health Organization.
Yet, migraine often is undiagnosed and left untreated. Dr. Amaal Starling, a neurologist at Mayo Clinic, says because the neurologic disease is so incapacitating, it is important to have a variety of treatment options. Dr. Starling is the lead author of a new study that looked at single pulse transcranial magnetic stimulation for the preventive treatment of migraine.
A migraine. It’s much more than a headache. And it can be debilitating.
“It’s a neurologic disease that has light sensitivity, sound sensitivity, motion sensitivity, nausea, vomiting. There are so many components,” says Dr. Starling.
There is no cure for migraine but there is a new option cleared by the U.S. Food and Drug Administration for the acute and preventive treatment of migraine.
“The device is called a single-pulse transcranial magnetic stimulation device,” says Dr. Starling.
She says the device transmits a signal to the brain, reducing brain hyperexcitability.
“Place it on the back of the head just like that [beeping]’ and then you push these two buttons,” says Dr. Starling. “And that administers a pulse.”
The first step, says Dr. Starling, is to get people with migraine to their health care provider so they can be properly diagnosed and treated.
Learn more: Mayo Clinic Minute: New device can prevent migraine attacks
The Latest on: Migraine
[google_news title=”” keyword=”migraine” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Migraine
- This New FDA-Approved Nasal Spray Could Help With Migraineon March 23, 2023 at 8:32 am
A new FDA-approved migraine nasal spray might be available as early as July.Pfizer's nasal spray Zavzpret offers an alternative for people who can't take oral medications due to nausea, or those who ...
- Pfizer recalls prescription migraine medication due to poisoning risk for childrenon March 23, 2023 at 7:48 am
Pfizer is recalling 4.2 million packs of Nurtec ODT prescription drugs due to the failure to meet child-resistant packaging requirements, posing a risk of poisoning to children, according to a notice ...
- Migraine Drugs Market Industrial Study Forecast to 2031on March 23, 2023 at 12:44 am
Migraine Drugs Market research report aims to provide valuable insights and a regional outlook for future market ...
- Acute Migraine Treatment Market Top Players, Revenue, Share, Future Trends, Size, Report and Forecast 2028on March 22, 2023 at 4:46 am
Acute migraine is a neurological condition that affects millions of people worldwide. It is characterized by severe headaches that can last for hours or even days. The pain is often accompanied by ...
- Pfizer Recalls Millions of Packs of the Migraine Drug Nurtec ODT Due to Child Safety Concernson March 21, 2023 at 6:12 am
Pharmaceutical company Pfizer is recalling more than four million packages of the prescription migraine medication Nurtec ODT (rimegepant). The reason for the recall is that the packaging is not child ...
- Can Chronic Migraine Lead To Long-Term Brain Damage?on March 20, 2023 at 12:47 pm
The sensitivity of a migraine patient's brain to different triggers varies on different days. There is a stage of prodrome 1-2 hours before the headache where the patient feels fatigued ...
- Migraine: Terms to Knowon March 16, 2023 at 5:00 pm
If you have migraine headaches, you actually have a medical condition called migraine. As you get treatment for it, you’re going to need to learn a new language when it comes to symptoms and ...
- Pfizer recalls migraine drug Nurtec ODT after millions of products lacked child resistant packagingon March 16, 2023 at 11:46 am
Consumers do not need to throw away the recalled Nurtec ODT or return it. Instead, they should contact Pfizer for a free child resistant pouch.
- This New Nasal Spray Could Provide Migraine Relief in Just 15 Minuteson March 14, 2023 at 5:30 am
Zavzpret is a new nasal spray to treat migraine headaches in adults. But how does the medication work and who should try the new FDA-approved medication?
via Bing News